BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16596639)

  • 1. Crystal structures of the complexes of a group IIA phospholipase A2 with two natural anti-inflammatory agents, anisic acid, and atropine reveal a similar mode of binding.
    Singh N; Jabeen T; Pal A; Sharma S; Perbandt M; Betzel C; Singh TP
    Proteins; 2006 Jul; 64(1):89-100. PubMed ID: 16596639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific binding of non-steroidal anti-inflammatory drugs (NSAIDs) to phospholipase A2: structure of the complex formed between phospholipase A2 and diclofenac at 2.7 A resolution.
    Singh N; Jabeen T; Sharma S; Somvanshi RK; Dey S; Srinivasan A; Singh TP
    Acta Crystallogr D Biol Crystallogr; 2006 Apr; 62(Pt 4):410-6. PubMed ID: 16552142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipase A2 as a target protein for nonsteroidal anti-inflammatory drugs (NSAIDS): crystal structure of the complex formed between phospholipase A2 and oxyphenbutazone at 1.6 A resolution.
    Singh N; Jabeen T; Somvanshi RK; Sharma S; Dey S; Singh TP
    Biochemistry; 2004 Nov; 43(46):14577-83. PubMed ID: 15544328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the complex of the secretory phospholipase A2 from Daboia russelli pulchella with an endogenic indole derivative, 2-carbamoylmethyl-5-propyl-octahydro-indol-7-yl-acetic acid at 1.8 A resolution.
    Balasubramanya R; Chandra V; Kaur P; Singh TP
    Biochim Biophys Acta; 2005 Sep; 1752(2):177-85. PubMed ID: 16122995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures and binding studies of the complexes of phospholipase A2 with five inhibitors.
    Shukla PK; Gautam L; Sinha M; Kaur P; Sharma S; Singh TP
    Biochim Biophys Acta; 2015 Apr; 1854(4):269-77. PubMed ID: 25541253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional structure of a presynaptic neurotoxic phospholipase A2 from Daboia russelli pulchella at 2.4 A resolution.
    Chandra V; Kaur P; Srinivasan A; Singh TP
    J Mol Biol; 2000 Mar; 296(4):1117-26. PubMed ID: 10686108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asp-49 is not an absolute prerequisite for the enzymic activity of low-M(r) phospholipases A2: purification, characterization and computer modelling of an enzymically active Ser-49 phospholipase A2, ecarpholin S, from the venom of Echis carinatus sochureki (saw-scaled viper).
    Polgár J; Magnenat EM; Peitsch MC; Wells TN; Clemetson KJ
    Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):961-8. PubMed ID: 8921006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of specific peptide inhibitors of phospholipase A2: structure of a complex formed between Russell's viper phospholipase A2 and a designed peptide Leu-Ala-Ile-Tyr-Ser (LAIYS).
    Chandra V; Jasti J; Kaur P; Dey S; Srinivasan A; Betzel Ch; Singh TP
    Acta Crystallogr D Biol Crystallogr; 2002 Oct; 58(Pt 10 Pt 2):1813-9. PubMed ID: 12351825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of catalytic function by molecular association: structure of phospholipase A2 from Daboia russelli pulchella (DPLA2) at 1.9 A resolution.
    Chandra V; Kaur P; Jasti J; Betzel C; Singh TP
    Acta Crystallogr D Biol Crystallogr; 2001 Dec; 57(Pt 12):1793-8. PubMed ID: 11717491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous inhibition of anti-coagulation and inflammation: crystal structure of phospholipase A2 complexed with indomethacin at 1.4 A resolution reveals the presence of the new common ligand-binding site.
    Singh N; Kumar RP; Kumar S; Sharma S; Mir R; Kaur P; Srinivasan A; Singh TP
    J Mol Recognit; 2009; 22(6):437-45. PubMed ID: 19462410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dynamics simulations reveal structural insights into inhibitor binding modes and functionality in human Group IIA phospholipase A
    Kim RR; Malde AK; Nematollahi A; Scott KF; Church WB
    Proteins; 2017 May; 85(5):827-842. PubMed ID: 28056488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of phospholipase A2 inhibition for the synthesis of prostaglandins by the plant alkaloid aristolochic acid from a 1.7 A crystal structure.
    Chandra V; Jasti J; Kaur P; Srinivasan A; Betzel Ch; Singh TP
    Biochemistry; 2002 Sep; 41(36):10914-9. PubMed ID: 12206661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-steroidal anti-inflammatory drugs as potent inhibitors of phospholipase A2: structure of the complex of phospholipase A2 with niflumic acid at 2.5 Angstroms resolution.
    Jabeen T; Singh N; Singh RK; Sharma S; Somvanshi RK; Dey S; Singh TP
    Acta Crystallogr D Biol Crystallogr; 2005 Dec; 61(Pt 12):1579-86. PubMed ID: 16301791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of specific peptide inhibitors for group I phospholipase A2: structure of a complex formed between phospholipase A2 from Naja naja sagittifera (group I) and a designed peptide inhibitor Val-Ala-Phe-Arg-Ser (VAFRS) at 1.9 A resolution reveals unique features.
    Singh RK; Vikram P; Makker J; Jabeen T; Sharma S; Dey S; Kaur P; Srinivasan A; Singh TP
    Biochemistry; 2003 Oct; 42(40):11701-6. PubMed ID: 14529280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and pharmacological comparison of daboiatoxin from Daboia russelli siamensis with viperotoxin F and vipoxin from other vipers.
    Gopalan G; Thwin MM; Gopalakrishnakone P; Swaminathan K
    Acta Crystallogr D Biol Crystallogr; 2007 Jun; 63(Pt 6):722-9. PubMed ID: 17505111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural characterization of myotoxic ecarpholin S from Echis carinatus venom.
    Zhou X; Tan TC; Valiyaveettil S; Go ML; Kini RM; Velazquez-Campoy A; Sivaraman J
    Biophys J; 2008 Oct; 95(7):3366-80. PubMed ID: 18586854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification, crystallization and preliminary x-ray crystallographic analysis of a phospholipase A2 from Daboia russelli pulchella.
    Chandra V; Nagpal A; Srinivasan A; Singh TP
    Acta Crystallogr D Biol Crystallogr; 1999 Apr; 55(Pt 4):925-6. PubMed ID: 10089336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structures of the free and anisic acid bound triple mutant of phospholipase A2.
    Sekar K; Vaijayanthi Mala S; Yogavel M; Velmurugan D; Poi MJ; Vishwanath BS; Gowda TV; Jeyaprakash AA; Tsai MD
    J Mol Biol; 2003 Oct; 333(2):367-76. PubMed ID: 14529623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional effects of tryptophans inserted into the membrane-binding and substrate-binding sites of human group IIA phospholipase A2.
    Nemec KN; Pande AH; Qin S; Bieber Urbauer RJ; Tan S; Moe D; Tatulian SA
    Biochemistry; 2006 Oct; 45(41):12448-60. PubMed ID: 17029400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray structure at 1.76 A resolution of a polypeptide phospholipase A2 inhibitor.
    Devedjiev Y; Popov A; Atanasov B; Bartunik HD
    J Mol Biol; 1997 Feb; 266(1):160-72. PubMed ID: 9054978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.